Gruber, M., Ferrone, L., Puhr, M., Santer, F. R., Furlan, T., Eder, I. E., . . . Culig, Z. (2020). p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer. Endocr Relat Cancer.
Citação norma ChicagoGruber, Martina, et al. "P300 Is Upregulated By Docetaxel and Is a Target in Chemoresistant Prostate Cancer." Endocr Relat Cancer 2020.
Citação norma MLAGruber, Martina, et al. "P300 Is Upregulated By Docetaxel and Is a Target in Chemoresistant Prostate Cancer." Endocr Relat Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.